Cases & Deals

Celgene enters into strategic collaboration with Quanticel to develop cancer drugs

Clients Celgene Corporation

Jones Day assisted Celgene Corporation in a strategic collaboration with Quanticel Pharmaceuticals Inc. to discover and develop first-in-class cancer drugs including the acquisition of an equity stake and an exclusive option to acquire Quanticel.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.